Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa.
BACKGROUND:We aimed to establish the prevalence of amphotericin B deoxycholate (AmBd)-related toxicities among South African patients with cryptococcosis and determine adherence to international recommendations to prevent, monitor and manage AmBd-related toxicities. METHODS:Clinical data were collec...
Main Authors: | Susan Meiring, Melony Fortuin-de Smidt, Ranmini Kularatne, Halima Dawood, Nelesh P Govender, GERMS-SA |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-07-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4965057?pdf=render |
Similar Items
-
Population pharmacokinetic model and meta-analysis of outcomes of amphotericin B deoxycholate use in adults with cryptococcal meningitis
by: Stott, K, et al.
Published: (2018) -
Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa.
by: Vanessa Quan, et al.
Published: (2019-01-01) -
Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa
by: Melony C. Fortuin-de Smidt, et al.
Published: (2015-01-01) -
MRSA bacteraemia complicating amphotericin B treatment of cryptococcal meningitis
by: J Scriven, et al.
Published: (2013-09-01) -
Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days
by: Joanne Livermore, et al.
Published: (2014-02-01)